Rheumatoid arthritis vs. psoriasis: two different TNF inhibitor...

added blog Health

2026-04-16 09:47:32 -

Rheumatoid arthritis vs. psoriasis: two different TNF inhibitor markets

Rheumatoid arthritis (RA) is the largest indication — it affects 1.3 million Americans, and TNF inhibitors are first‑line after methotrexate. Psoriasis is the fastest‑growing indication, driven by the approval of TNF inhibitors for psoriatic arthritis and plaque psoriasis. The TNF alpha inhibitors market research shows that psoriasis will grow at over 4% CAGR, faster than RA....

0 Comments 0 Shares 9 Views 0 Reviews